Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is now Q4 2021
Most likely as are many posts, oblique.
really
12
MAY
2021
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)
FOR IMMEDIATE RELEASE
CONTACTS
Dave Innes
804-513-4758
dinnes@nwbio.com
Les Goldman
240-234-0059
lgoldman@nwbio.com
Application Submitted to MHRA for Certification of Sawston Facility
BETHESDA, Md., May 12, 2021 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that an application for certification of the manufacturing facility in Sawston, UK has been submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA). The Company also provided a process update on the DCVax®-L Phase III Trial.
On May 7, the application package was submitted to the MHRA requesting the certification of the Sawston facility to produce Good Manufacturing Practice (GMP) clinical grade medical products for patients. This application represents the culmination of more than 2 years of preparations, including more than a year conducting these efforts under challenging COVID-19 restrictions and conditions.
Dcvax has had that approval for 7 years now and it was the first to be given the status in the UK
Look at adverse for chemotherapy if you want to try and understand how come some therapies aren’t withdrawn from approval status. Even ibuprofen, that list of adverse is long on that over the counter item.
Merck would definitely not want dcvax. They don’t want anyone cured.
My insinuation is more favorable and speedier certification for big pharma . Whereas, a small biotech has to actually pass a real certification , but maybe it is only the US where money makes things go quicker.
Many things have passed muster recently in the world for Moderna , Pfiezer and J&J with almost no time , clinical effort and safety results, compared to the magnified process used to creat dcvax-l that actually works without killing any people.
I realize the current wait is for a facility certification, but it seems processes proceed faster for others.
Probably just me who feels there is a bias.
I wonder why a rubber stamped certification hasn’t been announced like they would have for big Pharma?
No, it is down because little minute by minute traders didn’t make 100% profit for no effort and thus, they sell at a loss.
I wonder if today’s sellers all live in the same trailer park?
No, Nasdaq bring large investors and people with brains and less two bit traders.
Not at all , because that is why the specialist for up-listing were hired, to put things in place with the exchange in anticipation of the up-listing.
Shorts grasp at straws to support their failing positions each and everyday. They could just cover their short at $.18 but they are not that bright. Soon they will meet at the hanging tree.
I agree with your more informed opinion.
I wonder what the chance is of approval in Israel and then Japan with all the inroads Merck has there, after approval in UK is issued and US FDA follows along as a me too?
They chose to execute and only sell a few to cover the purchase at the warrant price.
$2.15 would be a pivotal phycological target price to hold through and keep going forward with strength to set up for UK approval of dcvax.
you are quoting total for day not total for price range. Total volume now for price range at 12:39:31. 520339
total volume at 515839 for $1.43 - $1.44
Expect a quick approval in the UK , based on dcvax being one of the first to get approval for use in their early use program EAMS in 2014
https://www.pharmatimes.com/news/nw_bio_cancer_therapy_first_in_uk_early_access_scheme_1002475
They are acting like a short term loan and care nothing about long term . Possibly, the warrants exercised are ones they got for extending the warrant exercise period . They got a lot of warrants as incentive, when they agreed to note exercise by the original agreed date. That bonus type of thought process would have been set up to insure a steady flow of money coming in as needed by Northwest, without multiple millions hitting at once.
Warrants exercised is no problem, but when they turn and sell immediately while overwhelming buyers, only shows their total ignorance about ultimate share price. I guess an IQ test isn’t given to those who got the chance to exercise warrants.
marching through mud and scum is always hard, but in the end you arrive at your objective
Still no real trading to drive price higher. There needs to be a 25 million share day to move these little traders along and get some serious money invested.
Only need another dollar to be priced as if TLD was getting released shortly , like when $2.55 was printed.
If TLD is as good as many of us believe , a threat of partnership or buy out offer may be made soon after data release. Of course, if Sawston approval , then if UK MHRA approval of dcvax is forecast to happen shortly after TLD , I doubt there will be any large warrant holders acting like the little day traders who can’t seem to hold a stock for 24 hrs to save their lives.
Great dcvax results, will cause epic stock results. I find it hard to believe that a large pharma is not involved and working very close inside.
I’ve been meaning to have a quick visit with a couple of my confidants.
So true.
There is zero percentage value in shorting nwbo. It is only hate and unfounded hope of failure that makes anyone short NWBO.
Thanks for the info
They should be worried if they want to own this stock. Even a dollars more than present price will be shown to have been an enormously underpriced value.
You bring up “paying dividends” and know no developing biotech has ever paid dividends with zero income while working to keep lights on with warrants.
Many without ethics have no concept of being ethical.
No one with a thought of an info drop at any time would sell
Dr Linda Liau pointed out it was paramount to have tumor tissue frozen properly even now. It pointed out in the past that improper procedures of preserving tissue made the sample useless.
Hedge funds? 300,000 shares sold today could be any normal shareholder
Dcvax should be in the top ten , if not #1
A hostile bid around $10 would get over 500,000,000 shares cashed in as fast as the system could process the sales.
There are quite a few who would love $7 right now.